IL6 and type 2 diabetes mellitus: In a 2013 meta‐analysis, a dose‐response relationship between IL‐6 and risk of new onset T2D was observed (Wang et al., 2013), suggesting that inflammatory dysregulation exists prior to diabetes diagnosis.